LIN28B gene polymorphisms modify hepatoblastoma susceptibility in Chinese children

Abstract

Hepatoblastoma is one of the malignant liver tumors in children. However, genetic mechanisms underpinning the initiation of hepatoblastoma remain largely unclear. The previous study showed that lin-28 homolog B (LIN28B) might play a role in the development of hepatoblastoma. To detect the association between LIN28B gene polymorphisms and hepatoblastoma risk in Chinese children, we conducted a five-center case-control study of 275 hepatoblastoma patients and 1018 cancer-free controls. Four potentially functional polymorphisms were genotyped using the Taqman method. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to evaluate the strength of the associations. We found that the rs314276 C>A polymorphism (AA vs. CC: adjusted OR=2.05, 95% CI=1.36-3.10, P=0.0006; AA vs. CA/CC: adjusted OR=2.11, 95% CI=1.43-3.12, P=0.0002) and rs9404590 T>G (GG vs. TT: adjusted OR=1.89, 95% CI=1.20-3.00, P=0.007; GG vs. TT/TG: adjusted OR=1.87, 95% CI=1.20-2.92, P=0.006) were associated with increased hepatoblastoma risk. Combination analysis of risk genotypes showed that patients with four risk genotypes had a higher chance of developing hepatoblastoma than carriers of 1 to 3 risk genotypes. Stratification analysis showed the significant association between the rs314276 AA genotype and hepatoblastoma risk in both age and sex groups, as well as clinical stages III+IV cases. The rs9404590 GG genotype was associated with hepatoblastoma risk in participants' ≥17 months, in females, and for those with clinical stages III+IV disease. Furthermore, four risk genotypes confer higher hepatoblastoma susceptibility in both age and sex groups, as well as groups with clinical stages III+IV disease. Genotype-based gene expression analysis confirmed that the rs9404590 T>G polymorphism was significantly associated with altered LIN28B gene expression. We further validated our findings using false-positive probability analysis. This finding suggested that LIN28B gene polymorphisms may be associated with an increased predisposition to hepatoblastoma.

YTHDC1 gene polymorphisms and hepatoblastoma susceptibility in Chinese children: A seven‐center case–control study

“…Furthermore, false-positive probability analysis (FPRP) was used to notarize the significant results. 33 All data were analyzed using SAS, release 9.1 (SAS Institute, Cary, NC, USA). p < 0.05 was considered statistically significant.…”

“…Adjusted ORs were calculated after adjusting for age, gender, omitting the corresponding stratify factor. Furthermore, false‐positive probability analysis (FPRP) was used to notarize the significant results 33 . All data were analyzed using SAS, release 9.1 (SAS Institute, Cary, NC, USA).…”

LIN28A polymorphisms and hepatoblastoma susceptibility in Chinese children

“…Included patients provided their necessary written informed consent and trained interviewers collected their demographic information. The complete criterion for selecting participants was described previously 25 , 26 . Approval for this study was obtained from the ethics committee of each participating hospital.…”

The Genetic Changes of Hepatoblastoma

“…They can bind to the target RNAs, involved separately or jointly in human development and metabolism, to affect cancer occurrence via inhibition of let-7 miRNA (90). Yang et al enrolled 275 hepatoblastoma cases and 1,018 healthy controls to prove LIN28B SNPs (rs94904590 T>G and rs314276 C>A) could increase the risk of hepatoblastoma (61). The LIN28A SNP (rs3811464 G>A) in hepatoblastoma affected hepatoblastoma in a low-penetrating manner because the significant result was only found in the stratified analysis (91).…”